Challenge Pools of Hepatitis C Virus Genotypes 1-6 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver-Chimeric Mouse Models.
J. Infect. Dis.
2010
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies.
J. Virol.
2010

Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins.
J. Gen. Virol.
2010;91;Pt 3


Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt.
J. Clin. Virol.
2009;46;2


The size of the viral inoculum contributes to the outcome of hepatitis B virus infection.
J. Virol.
2009;83;19

Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
J. Viral Hepat.
2009;16;9

Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.
Infect. Immun.
2009;77;9

Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding.
Proc. Natl. Acad. Sci. U.S.A.
2009;106;32
Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.
J. Infect. Dis.
2009;200;1



Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles.
Clin. Vaccine Immunol.
2009;16;3

Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.
Clin. Infect. Dis.
2008;47;8

Apolipoprotein c1 association with hepatitis C virus.
J. Virol.
2008;82;19


Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.
J. Virol.
2008;82;16

Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo.
J. Virol.
2008;82;14

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.
Hepatology
2008;47;6

Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus.
Proc. Natl. Acad. Sci. U.S.A.
2008;105;11


Hepatitis E: an emerging awareness of an old disease.
J. Hepatol.
2008;48;3

Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.
J. Virol.
2008;82;3

Development of a TaqMan assay for the six major genotypes of hepatitis C virus: comparison with commercial assays.
J. Med. Virol.
2008;80;1

Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived.
J. Med. Virol.
2008;80;1

Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus.
J. Virol.
2008;82;2


Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.
J. Immunol. Methods
2007;328;1-2


Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
J. Virol.
2007;81;23

A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA.
Epidemiol. Infect.
2007;135;7


In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.
J. Virol.
2007;81;13


Using improved technology for filter paper-based blood collection to survey wild Sika deer for antibodies to hepatitis E virus.
J. Virol. Methods
2007;142;1-2

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
Proc. Natl. Acad. Sci. U.S.A.
2007;104;22


ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.
J. Virol.
2006;80;21


The half-life of hepatitis B virions.
Hepatology
2006;44;5
Quantification of hepatitis B virus genomes and infectivity in human serum samples.
Transfusion
2006;46;10

A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo.
Proc. Natl. Acad. Sci. U.S.A.
2006;103;10

Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Clin. Infect. Dis.
2006;42;5

Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay.
J. Gen. Virol.
2006;87;Pt 3

Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein.
Proc. Natl. Acad. Sci. U.S.A.
2006;103;9
Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
Intervirology
2006;49;3

Dynamics of hepatitis B virus clearance in chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
2005;102;49
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
Hepatology
2005;42;5



Thermal stability of hepatitis E virus.
J. Infect. Dis.
2005;192;5
The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques.
J. Virol.
2005;79;11
A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
Vaccine
2005;23;24
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
Proc. Natl. Acad. Sci. U.S.A.
2005;102;12

In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and replicons.
J. Virol.
2005;79;2
Running like water--the omnipresence of hepatitis E.
N. Engl. J. Med.
2004;351;23
Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
J. Virol.
2004;78;23
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
J. Virol.
2004;78;23
An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
Vaccine
2004;22;20


Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
Gastroenterology
2004;126;7

Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV.
J. Gen. Virol.
2004;85;Pt 6
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.
Proc. Natl. Acad. Sci. U.S.A.
2004;101;20

In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein.
J. Virol.
2004;78;9
Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
J. Virol.
2004;78;9

Genomic analysis of the host response to hepatitis B virus infection.
Proc. Natl. Acad. Sci. U.S.A.
2004;101;17

Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
2004;101;7
Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine.
Vaccine
2003;22;2

In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes.
Proc. Natl. Acad. Sci. U.S.A.
2003;100;24
The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.
Proc. Natl. Acad. Sci. U.S.A.
2003;100;20
Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.
Clin. Diagn. Lab. Immunol.
2003;10;4

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.
Vaccine
2003;21;19-20

Hepatitis E virus.
Rev. Med. Virol.
2003;13;3

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.
J. Virol.
2003;77;1
Prevalence study of antibody to ratborne pathogens and other agents among patients using a free clinic in downtown Los Angeles.
J. Infect. Dis.
2002;186;11

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.
Proc. Natl. Acad. Sci. U.S.A.
2002;99;24

Genomic analysis of the host response to hepatitis C virus infection.
Proc. Natl. Acad. Sci. U.S.A.
2002;99;24

The challenge of developing a vaccine against hepatitis C virus.
J. Hepatol.
2002;37;5
DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.
Vaccine
2002;20;27-28
Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.
Vaccine
2002;20;27-28

Identification of VP1/2A and 2C as virulence genes of hepatitis A virus and demonstration of genetic instability of 2C.
J. Virol.
2002;76;17

Relative infectivity of hepatitis A virus by the oral and intravenous routes in 2 species of nonhuman primates.
J. Infect. Dis.
2002;185;11
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.
Proc. Natl. Acad. Sci. U.S.A.
2002;99;5
Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus.
Virology
2002;292;1
High prevalence of hepatitis E antibodies among Danish prisoners and drug users.
J. Med. Virol.
2002;66;1

Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element.
Proc. Natl. Acad. Sci. U.S.A.
2001;98;26

Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.
Vaccine
2001;20;5-6


Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees.
J. Med. Virol.
2001;65;4

Identification of the 5' terminal sequence of the SAR-55 and MEX-14 strains of hepatitis E virus and confirmation that the genome is capped.
J. Med. Virol.
2001;65;2

A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species.
Proc. Natl. Acad. Sci. U.S.A.
2001;98;20
High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype.
J. Virol. Methods
2001;97;1-2

Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains.
J. Gen. Virol.
2001;82;Pt 7

Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a.
J. Viral Hepat.
2001;8;3
Detection of antibodies to HAV 3C proteinase in experimentally infected chimpanzees and in naturally infected children.
Vaccine
2001;19;20-22

Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.
Intervirology
2001;44;2-3



Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975.
Rev. Med. Virol.
2001;11;1


Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Virology
2000;277;2

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
2000;97;24

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
Hepatology
2000;32;3

Hepatitis B virus mutants and efficacy of vaccination.
Lancet
2000;356;9231
Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
J. Virol.
2000;74;12

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
Science
2000;288;5464

High prevalence of TT virus (TTV) in naive chimpanzees and in hepatitis C virus-infected humans: frequent mixed infections and identification of new TTV genotypes in chimpanzees.
J. Gen. Virol.
2000;81;Pt 4
Identification of hepatitis B virus indigenous to chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
2000;97;4

Hepatitis E virus infection.
Lancet
2000;355;9203


Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
J. Immunol.
2000;164;3

Clinical significance of hepatitis C virus genotypes and quasispecies.
Semin. Liver Dis.
2000;20;1

Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection.
Hepatology
2000;31;1

High prevalence of TT virus (TTV) infection in patients on maintenance hemodialysis: frequent mixed infections with different genotypes and lack of evidence of associated liver disease.
J. Med. Virol.
1999;59;3
Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population.
J. Med. Virol.
1999;59;3
Evidence that the genomic RNA of hepatitis E virus is capped.
J. Virol.
1999;73;10

Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.
Virology
1999;262;1

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
Hepatology
1999;30;3
Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993).
J. Gen. Virol.
1999;80 ( Pt 7)


DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.
Vaccine
1999;17;15-16
Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee.
J. Infect. Dis.
1999;179;4

In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone.
Proc. Natl. Acad. Sci. U.S.A.
1999;96;5
Hepatitis A virus translation is rate-limiting for virus replication in MRC-5 cells.
Virology
1999;254;2
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus.
J. Virol.
1998;72;12

Utilization of chimeras between human (HM-175) and simian (AGM-27) strains of hepatitis A virus to study the molecular basis of virulence.
J. Virol.
1998;72;9

Evidence for a bidirectional promoter complex within the X gene of woodchuck hepatitis virus.
Virus Res.
1998;56;1

Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope.
Hepatology
1998;27;6
Infection of a chimpanzee with hepatitis C virus grown in cell culture.
J. Gen. Virol.
1998;79 ( Pt 6)

Comparison of tests for antibody to hepatitis E virus.
J. Med. Virol.
1998;55;2
Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.
J. Viral Hepat.
1998;5;3
The GDPAL region of the pre-S1 envelope protein is important for morphogenesis of woodchuck hepatitis virus.
Hepatology
1998;27;5

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.
Virology
1998;244;1

Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus.
J. Infect. Dis.
1998;177;4
Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group.
Hepatology
1998;27;3

Titration of recombinant woodchuck hepatitis virus DNA in adult woodchucks.
J. Med. Virol.
1998;54;2

Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV.
Arch. Virol.
1998;143;7

How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure.
Proc. Natl. Acad. Sci. U.S.A.
1997;94;25

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.
Vaccine
1997;15;17-18

African strains of hepatitis E virus that are distinct from Asian strains.
J. Med. Virol.
1997;53;2
A novel virus in swine is closely related to the human hepatitis E virus.
Proc. Natl. Acad. Sci. U.S.A.
1997;94;18

Hepatitis A among homosexual men and injection drug users: more evidence for vaccination.
Clin. Infect. Dis.
1997;25;3

Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus.
J. Infect. Dis.
1997;176;3

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.
Proc. Natl. Acad. Sci. U.S.A.
1997;94;16
Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees.
J. Virol.
1997;71;8


Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant.
J. Infect. Dis.
1997;175;3
Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.
Vaccine
1997;15;3

The quasispecies of hepatitis C virus and the host immune response.
Springer Semin. Immunopathol.
1997;19;1
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.
Proc. Natl. Acad. Sci. U.S.A.
1996;93;26
Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: implications for the study of hepatitis C virus in cell cultures.
J. Infect. Dis.
1996;174;6

Varicella in Chimpanzees.
J. Med. Virol.
1996;50;4

Progress toward the development of a genetically engineered attenuated hepatitis A virus vaccine.
J. Virol.
1996;70;11
A hydrophobic heptad repeat of the core protein of woodchuck hepatitis virus is required for capsid assembly.
J. Virol.
1996;70;10
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
Virology
1996;223;2
False-positive serologic test resulting from a probable yeast infection in a chimpanzee.
Clin. Diagn. Lab. Immunol.
1996;3;5

Hepatitis C virus-associated fulminant hepatic failure.
N. Engl. J. Med.
1996;335;9


DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.
Proc. Natl. Acad. Sci. U.S.A.
1996;93;14
Amplification of the full-length hepatitis A virus genome by long reverse transcription-PCR and transcription of infectious RNA directly from the amplicon.
Proc. Natl. Acad. Sci. U.S.A.
1996;93;9

A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees.
J. Infect. Dis.
1996;173;3
Hepatitis C virus: detection of intracellular virus particles by electron microscopy.
Hepatology
1996;23;2


Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV.
J. Infect. Dis.
1995;172;1
Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
J. Infect. Dis.
1995;171 Suppl 1

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.
Semin. Liver Dis.
1995;15;1


Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.
J. Infect. Dis.
1995;171;2

Genetic heterogeneity of the hepatitis C virus.
Int. Symp. Princess Takamatsu Cancer Res. Fund
1995;25

Hepatitis C and its sequelae: the biology of hepatitis C virus and implications for its control.
Int. Symp. Princess Takamatsu Cancer Res. Fund
1995;25


Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B.
J. Infect. Dis.
1995;171;1
Analysis of the X gene promoter of woodchuck hepatitis virus.
Virology
1994;205;1
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus.
Hepatology
1994;20;5


Successful passive and active immunization of cynomolgus monkeys against hepatitis E.
Proc. Natl. Acad. Sci. U.S.A.
1994;91;21

Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease.
J. Infect. Dis.
1994;170;3

A new Chinese isolate of hepatitis E virus: comparison with strains recovered from different geographical regions.
Virus Genes
1994;9;1

Sequence analysis of the core gene of 14 hepatitis C virus genotypes.
Proc. Natl. Acad. Sci. U.S.A.
1994;91;17


Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.
Proc. Natl. Acad. Sci. U.S.A.
1994;91;16


Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys.
J. Med. Virol.
1994;43;2
Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent.
Proc. Natl. Acad. Sci. U.S.A.
1994;91;8

Hepatitis viruses: changing patterns of human disease.
Proc. Natl. Acad. Sci. U.S.A.
1994;91;7
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.
J. Virol.
1994;68;3
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children.
Lancet
1994;343;8894
Virology of the hepatitis A epidemic in Italy.
Vox Sang.
1994;67 Suppl 4

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
Ann. Intern. Med.
1994;120;1

Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells.
J. Virol.
1994;68;1
In vivo transfection by hepatitis A virus synthetic RNA.
Arch. Virol. Suppl.
1994;9
High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.
J. Infect. Dis.
1993;168;6

Partial sequence comparison of eight new Chinese strains of hepatitis E virus suggests the genome sequence is relatively stable.
J. Med. Virol.
1993;41;3

Mutant woodchuck hepatitis virus genomes from virions resemble rearranged hepadnaviral integrants in hepatocellular carcinoma.
Proc. Natl. Acad. Sci. U.S.A.
1993;90;21

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.
Proc. Natl. Acad. Sci. U.S.A.
1993;90;17

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates.
J. Infect. Dis.
1993;168;2

Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro.
Proc. Natl. Acad. Sci. U.S.A.
1993;90;13

Variation in course of hepatitis E in experimentally infected cynomolgus monkeys.
J. Infect. Dis.
1993;167;6
2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture.
Virology
1993;194;2

The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees.
Virology
1993;194;1
Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.
Proc. Natl. Acad. Sci. U.S.A.
1993;90;7

The discovery of the hepatitis viruses.
Gastroenterology
1993;104;4
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.
J. Virol.
1993;67;4


The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.
J. Virol.
1993;67;3

Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.
Proc. Natl. Acad. Sci. U.S.A.
1993;90;5


Heterogeneity of the woodchuck hepatitis virus genome in a chronically infected woodchuck.
Virus Res.
1993;27;3

Importance of the polymerase chain reaction in the study of hepatitis C virus infection.
Int. J. Clin. Lab. Res.
1993;23;3
Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaptation to growth in cell culture and attenuation of virulence.
J. Med. Virol.
1993;39;1

Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues.
J. Hepatol.
1993;18 Suppl 2
cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets.
J. Virol.
1992;66;11

The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host.
J. Virol.
1992;66;9
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line.
Proc. Natl. Acad. Sci. U.S.A.
1992;89;12

Sequence analysis of the 5' noncoding region of hepatitis C virus.
Proc. Natl. Acad. Sci. U.S.A.
1992;89;11

The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia.
J. Infect. Dis.
1992;165;6
Hepatitis B and hepatitis C in emergency department patients.
N. Engl. J. Med.
1992;326;21
Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology.
Proc. Natl. Acad. Sci. U.S.A.
1992;89;6
Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaptation to growth in cell culture.
J. Virol.
1992;66;2


Characterization of a prototype strain of hepatitis E virus.
Proc. Natl. Acad. Sci. U.S.A.
1992;89;2
Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay.
Proc. Natl. Acad. Sci. U.S.A.
1992;89;1
Molecular basis of virulence and growth of hepatitis A virus in cell culture.
Vaccine
1992;10 Suppl 1

Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
Vaccine
1992;10 Suppl 1


Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
Vaccine
1992;10 Suppl 1
Hepatitis C in hospital employees with needlestick injuries.
Ann. Intern. Med.
1991;115;5

Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell culture.
J. Virol.
1991;65;9
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
N. Engl. J. Med.
1991;325;2

Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains.
J. Gen. Virol.
1991;72 ( Pt 7)
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.
Proc. Natl. Acad. Sci. U.S.A.
1991;88;8

Attempts to transmit hepatitis B virus to chimpanzees by arthropods.
S. Afr. Med. J.
1991;79;6

The nature of genetic variation among viruses.
J. Hepatol.
1991;13 Suppl 4


Biological and molecular comparisons of human (HM-175) and simian (AGM-27) hepatitis A viruses.
J. Hepatol.
1991;13 Suppl 4

Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infections.
Proc. Natl. Acad. Sci. U.S.A.
1990;87;23

19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage.
Infection
1990;18;6
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
Hepatology
1990;12;4 Pt 1

Non-specificity of anti-HCV test for seroepidemiological analysis.
Lancet
1990;336;8717

Hepatitis B virus DNA detection and comparison with hepatitis B surface antigen.
Gastroenterol. Jpn.
1990;25 Suppl 2
Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.
Gastroenterology
1990;99;3

Early events in hepatitis C virus infection of chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
1990;87;16
Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus.
Vaccine
1990;8;2


Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.
Proc. Natl. Acad. Sci. U.S.A.
1990;87;6
The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees.
J. Hepatol.
1990;10;1

Riboprobe assay for HDV RNA: a sensitive method for the detection of the HDV genome in clinical serum samples.
J. Med. Virol.
1990;30;1

Enterically transmitted non-A, non-B hepatitis.
Prog Liver Dis
1990;9
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA.
J. Virol.
1989;63;12
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
N. Engl. J. Med.
1989;321;22
Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs.
J. Infect. Dis.
1989;160;5
Cytoplasmic antigen in hepatocytes of chimpanzees infected with non-A, non-B hepatitis virus or hepatitis delta virus: relationship to interferon.
Hepatology
1989;10;5

Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.
Proc. Natl. Acad. Sci. U.S.A.
1989;86;20

In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide-stimulated peripheral blood lymphocytes.
J. Infect. Dis.
1989;160;4

Reappearance of hepatitis D virus (HDV) replication in chronic hepatitis B virus carrier chimpanzees rechallenged with HDV.
J. Infect. Dis.
1989;160;4

Basis of hepatitis delta virus disease?
Nature
1989;341;6238

An African primate lentivirus (SIVsm) closely related to HIV-2.
Nature
1989;339;6223
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.
Science
1989;244;4902
Molecular cloning of feline immunodeficiency virus.
Proc. Natl. Acad. Sci. U.S.A.
1989;86;7
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion.
Proc. Natl. Acad. Sci. U.S.A.
1989;86;7

Complete nucleotide sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host.
Proc. Natl. Acad. Sci. U.S.A.
1989;86;6

Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues.
J. Virol.
1989;63;3

NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
Ann. Intern. Med.
1989;110;5

Compact organization of the hepatitis B virus genome.
Hepatology
1989;9;2

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.
Proc. Natl. Acad. Sci. U.S.A.
1989;86;1
The size of the hepatitis delta agent.
J. Med. Virol.
1989;27;1
Does non-A, non-B hepatitis cause hepatocellular carcinoma?
Cancer Detect. Prev.
1989;14;2
Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma.
Infection
1989;17;1
Molecular analysis of hepatitis B virus infection.
Transfus Med Rev
1988;2;4

Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees.
Hepatology
1988;8;6
Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection.
Virology
1988;167;1

Chronic hepatitis D virus (HDV) infection in hepatitis B virus carrier chimpanzees experimentally superinfected with HDV.
J. Infect. Dis.
1988;158;1
Site-directed ELISA identifies a highly antigenic region of the simian immunodeficiency virus transmembrane glycoprotein.
AIDS Res. Hum. Retroviruses
1988;4;3
Waterborne non-A, non-B hepatitis.
Lancet
1988;1;8585

Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis.
Lancet
1988;1;8585
Studies of prototype live hepatitis A virus vaccines in primate models.
J. Infect. Dis.
1988;157;2


Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome.
Virology
1988;162;1
Detection of hepatitis B virus DNA in asymptomatic hepatitis B surface antigen carriers: relation to sexual transmission.
Am. J. Epidemiol.
1987;126;4
Determining the size of non-A, non-B hepatitis virus by filtration.
J. Infect. Dis.
1987;156;4

Report of a workshop: waterborne non-A, non-B hepatitis.
J. Infect. Dis.
1987;156;4
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.
J. Virol.
1987;61;10

A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus.
J. Infect. Dis.
1987;156;4

Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
1987;84;13

Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults.
Gastroenterology
1987;92;6
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus.
Proc. Natl. Acad. Sci. U.S.A.
1987;84;8
Serological response to the hepatitis delta virus in hepatitis D.
Lancet
1987;1;8531

Hepatocarcinogenicity of the woodchuck hepatitis virus.
Proc. Natl. Acad. Sci. U.S.A.
1987;84;3
An epidemic of hepatitis A in an institution for young children.
Am. J. Epidemiol.
1987;125;2

Titration of the infectivity of hepatitis D virus in chimpanzees.
J. Infect. Dis.
1987;155;1

Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses.
J. Virol.
1987;61;1

Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen.
J. Virol.
1986;60;3

Failure to detect polyalbumin-binding sites on the woodchuck hepatitis virus surface antigen: implications for the pathogenesis of hepatitis B virus in humans.
J. Virol.
1986;60;3

Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece.
J. Med. Virol.
1986;20;4

Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay.
Hepatology
1986;6;6
Epidemiologic aspects of Santa Marta hepatitis over a 40-year period.
Hepatology
1986;6;6
Specific histologic features of Santa Marta hepatitis: a severe form of hepatitis delta-virus infection in northern South America.
Hepatology
1986;6;6

Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non-A, non-B hepatitis in chimpanzees and their relation to D hepatitis.
Hepatology
1986;6;6

Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection.
Liver
1986;6;5


Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs.
J. Virol.
1986;60;1
Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiation.
Transfusion
1986;26;5

Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Hepatogastroenterology
1986;33;4
Fecal excretion of Greek strains of hepatitis A virus in patients with hepatitis A and in experimentally infected chimpanzees.
J. Infect. Dis.
1986;154;2

Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis.
J. Virol.
1986;58;1
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
Ann. Intern. Med.
1986;104;4

Use of monoclonal antibodies to determine if HBsAg of mixed subtype is one particle or two.
J. Virol. Methods
1986;13;1

Superimposed hepatitis and the effect on viral replication in chronic hepatitis B.
J. Hepatol.
1986;3 Suppl 2

Hepatitis delta virus disease.
Prog Liver Dis
1986;8
Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis.
J. Hepatol.
1986;2;3
IgM antibody to hepatitis B core antigen: a marker of infectivity.
N. Engl. J. Med.
1985;313;26

Double infections with hepatitis A and B viruses.
Liver
1985;5;6
Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience.
Gastroenterology
1985;89;6

Hepatitis B virus, hepatitis non-A, non-B virus and hepatitis delta virus in lyophilized antihemophilic factor: relative sensitivity to heat.
Hepatology
1985;5;6
Reactivation of chronic hepatitis B as acute viral hepatitis.
Ann. Intern. Med.
1985;103;3


Prevention of hepatitis B virus carriage of infants using HBV vaccine in Shanghai. Preliminary report of a randomized double-blind placebo-controlled trial.
Chin. Med. J.
1985;98;9
The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.
Hepatology
1985;5;4

Radioimmunoassay and characterization of woodchuck hepatitis virus core antigen and antibody.
Virus Res.
1985;2;4
Antibody to human parvovirus in outbreak of erythema infectiosum in Japan.
Lancet
1985;1;8435


A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine.
J. Med. Virol.
1985;15;4
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase.
Proc. Natl. Acad. Sci. U.S.A.
1985;82;7

Viral hepatitis in Colombia: a study of the "hepatitis of the Sierra Nevada de Santa Marta".
Hepatology
1985;5;2

Rheumatoid factor-like reactants in sera proven to transmit non-A, non-B hepatitis: a potential source of false-positive reactions in non-A, non-B assays.
Hepatology
1985;5;2
Prospects for second and third generation hepatitis B vaccines.
Hepatology
1985;5;1
Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
Hepatology
1984;4;6

Hepatitis delta virus infection of the liver.
Semin. Liver Dis.
1984;4;4

Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.
J. Virol.
1984;52;1
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.
J. Clin. Invest.
1984;74;4
Live recombinant vaccinia virus protects chimpanzees against hepatitis B.
Nature
1984;311;5981
Cell-mediated immunity to hepatitis B surface antigen in man.
Clin. Exp. Immunol.
1984;57;2
Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine.
Cell. Immunol.
1984;86;1

Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.
Proc. Natl. Acad. Sci. U.S.A.
1984;81;7

Delta hepatitis agent: structural and antigenic properties of the delta-associated particle.
Infect. Immun.
1984;43;3
Experimental infection of chimpanzees with the HBsAg-associated delta (delta) agent: an ultrastructural study.
J. Med. Virol.
1984;13;1

Molecular cloning and characterization of hepatitis A virus cDNA.
Proc. Natl. Acad. Sci. U.S.A.
1983;80;19

Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis.
Hepatology
1983;3;5
IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine.
J. Infect. Dis.
1983;148;2

Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.
Infect. Immun.
1983;41;2

Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
1983;80;8
A dot hybridisation assay for detection of rotavirus.
Lancet
1983;1;8324
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.
Nature
1983;302;5907
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers.
J. Infect. Dis.
1983;147;3
Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA.
Infect. Immun.
1983;39;3


Hepatitis A and non-A, non-B viral hepatitis in São Paulo, Brazil: epidemiological, clinical and laboratory comparisons in hospitalized patients.
Hepatology
1982;2;4
Non-A, non-B hepatitis in chimpanzees and marmosets.
J. Infect. Dis.
1981;144;6

Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers.
Am. J. Pathol.
1981;105;3

Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen.
Hepatology
1981;1;6
Donor transaminase and recipient hepatitis. Impact on blood transfusion services.
JAMA
1981;246;6

Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage.
Infect. Immun.
1981;32;1


The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier.
Hepatology
1981;1;2

Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations.
Hepatology
1981;1;2

Hepatitis B vaccines: present status.
Semin. Liver Dis.
1981;1;1



Non-A, non-B hepatitis after experimental transmission of malaria by inoculation of blood.
J. Infect. Dis.
1981;143;2
Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies.
Scand. J. Infect. Dis.
1981;13;1
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.
Infect. Immun.
1980;30;2
Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology.
Lancet
1980;2;8200

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.
Proc. Natl. Acad. Sci. U.S.A.
1980;77;10

Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
Lancet
1980;1;8180

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.
J. Infect. Dis.
1980;141;5


Type B hepatitis: a review of current prospects for a safe and effective vaccine.
Rev. Infect. Dis.
1980;2;3
New methods for the serodiagnosis of hepatitis A.
Gastroenterology
1980;78;5 Pt 1
Hepatitis A virus in the liver and intestine of marmosets after oral inoculation.
Infect. Immun.
1980;28;1

Detection of antibodies to single-stranded DNA in naturally acquired and experimentally induced viral hepatitis.
J. Med. Virol.
1980;6;1
Hepatitis type A, B, and non-A non-B in fulminant hepatitis.
Gut
1980;21;1
The role of acute hepatitis type A, B, and non-A non-B in the development of chronic active liver disease.
Scand. J. Gastroenterol.
1980;15;1
Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
Lancet
1979;2;8150
Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay.
Infect. Immun.
1979;26;1
Summary of an international workshop on hepatitis B vaccines.
J. Infect. Dis.
1979;140;4

Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness.
Am. J. Med. Sci.
1979;278;2
Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific.
Am. J. Epidemiol.
1979;110;3

Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees.
Science
1979;205;4402
The chronic sequelae of non-A, non-B hepatitis.
Ann. Intern. Med.
1979;91;1

Circulating immune complexes in non-A, non-B hepatitis. Possible masking of viral antigen.
Lancet
1979;1;8129

Non-A non-B hepatitis associated with chronic liver disease in a haemodialysis unit.
Lancet
1979;1;8123
Seroepidemiology of hepatitis A and B in Kenya. A rural population survey in Machakos District.
East Afr Med J
1979;56;3
Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B.
Scand. J. Gastroenterol.
1979;14;7
Localization of hepatitis A antigen in liver tissue by peroxidase-conjugated antibody method: light and electron microscopic studies.
J. Immunol.
1978;121;5
Non-A, non-B hepatitis.
JAMA
1978;240;13
Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus.
J. Infect. Dis.
1978;138;3
Immunofluorescence of hepatitis A virus antigen in chimpanzees.
Infect. Immun.
1978;21;2
The viral hepatitides.
Hosp Pract
1978;13;7

Hepatitis B vaccines. On the threshold.
Am. J. Clin. Pathol.
1978;70;1 Suppl
Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
Z Immunitatsforsch Immunobiol
1978;154;3

Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study.
Transfusion
1978;18;3
Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.
Klin. Wochenschr.
1978;56;6
Transmissible agent in non-A, non-B hepatitis.
Lancet
1978;1;8062


Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study.
Ann. Intern. Med.
1978;88;3


Hepatitis A virus infection: new insights from seroepidemiologic studies.
J. Infect. Dis.
1978;137;3
Antigens of hepatitis B virus: failure to detect HBeAg on the surfaces of HBsAg forms.
J. Gen. Virol.
1978;38;3

Non-A, non-B hepatitis.
Annu. Rev. Med.
1978;29
Serologic and animal inoculation studies of a communal outbreak of viral hepatitis, type A.
Am. J. Med. Sci.
1977;274;3
Detection of hepatitis A antigen by immunofluorescence.
Infect. Immun.
1977;18;2

The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study.
Am. J. Epidemiol.
1977;106;5

Antibody to hepatitis A antigen in children.
J. Pediatr.
1977;91;3

Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers.
Infect. Immun.
1977;17;3

Disparate response of monozygotic twins to hepatitis B virus infection.
J. Pediatr.
1977;91;2
Transmission of non-A, non-B hepatitis.
Ann. Intern. Med.
1977;87;1

Hepatitis type A and hemodialysis: a seroepidemiologic study in 15 U.S. centers.
Ann. Intern. Med.
1977;87;1
Etiology of sporadic hepatitis B surface antigen-negative hepatitis.
Ann. Intern. Med.
1977;87;1
Hepatitis A antigen: clinical implications.
Compr Ther
1977;3;7

Recent advances in the identification of hepatitis viruses.
Postgrad Med J
1977;53;621

Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed.
Ann. Intern. Med.
1977;87;1
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.
Infect. Immun.
1977;16;3


Antibody to hepatitis A antigen in institutionalized mentally retarded patients.
JAMA
1977;237;16

A microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools.
J. Immunol.
1977;118;4


Chimpanzee livers after infection with human hepatitis viruses A and B: Ultrastructural studies.
Arch. Pathol. Lab. Med.
1977;101;3
Non-B hepatitis in Melbourne: a serological study of hepatitis A virus infection.
Br Med J
1977;1;6055
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis.
N. Engl. J. Med.
1977;296;2
Virus-like particles and GB agent hepatitis.
Nature
1976;264;5583
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.
N. Engl. J. Med.
1976;295;17

Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer.
Lancet
1976;2;7989

The pathology of viral hepatitis types A and B in chimpanzees. A comparison.
Am. J. Pathol.
1976;85;1

Comparison of serological tests for antibody to hepatitis A antigen, using coded specimens from individuals infected with the MS-1 strain of hepatitis A virus.
Infect. Immun.
1976;14;4

Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants.
J. Immunol.
1976;117;4

Distribution of antibody to hepatitis a antigen in urban adult populations.
N. Engl. J. Med.
1976;295;14
Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs.
J. Immunol.
1976;117;3
Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B virus among household contacts.
J. Infect. Dis.
1976;134;3
Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection.
JAMA
1976;236;5
Hepatitis A and Down's syndrome: lack of an association.
J. Infect. Dis.
1976;134;2
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees.
J. Infect. Dis.
1976;134;1
Quantitation of antibody to hepatitis A antigen by immune electron microscopy.
Infect. Immun.
1976;13;4
Editorial: e: a third hepatitis B antigen?
N. Engl. J. Med.
1976;294;14
Mussel-associated viral hepatitis, type A: serological confirmation.
Lancet
1976;1;7959

Demonstration of subpopulations of Dane particles.
J. Virol.
1976;17;3

Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination.
Infect. Immun.
1976;13;3
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.
J. Immunol.
1976;116;2
IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemia.
Clin. Exp. Immunol.
1976;23;1
Hepatitis and Down's syndrome.
Am J Ment Defic
1976;80;4
Epidemiology of hepatitis B virus in an institution for mentally retarded persons.
Am J Ment Defic
1976;80;4
Correlation between fluorescent antibody detection of hepatitis B core antigen in liver biopsies and the presence of e antigen in serum.
Infect. Immun.
1976;13;1
Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus.
Am. J. Pathol.
1975;81;3
Experimental infection of chimpanzees with hepatitis A virus.
J. Infect. Dis.
1975;132;5
Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopic study.
Ann. Intern. Med.
1975;83;5
Clinical and serological analysis of transfusion-associated hepatitis.
Lancet
1975;2;7940
Hepatitis B virus infection in chimpanzees: titration of subtypes.
J. Infect. Dis.
1975;132;4
The emerging pattern of post-transfusion hepatitis.
Am. J. Med. Sci.
1975;270;2
Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus.
Infect. Immun.
1975;12;3
Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.
Am. J. Med. Sci.
1975;270;2
Viral hepatitis, type B, in experimental animals.
Am. J. Med. Sci.
1975;270;1
Review of infectivity studies in nonhuman primates with virus-like particles associated with MS-1 hepatitis.
Am. J. Med. Sci.
1975;270;1
Relationship of hepatitis A antigen to viral hepatitis.
Am. J. Med. Sci.
1975;270;1
Hepatitis B core antigen. Detection of antibody by radioimmunoprecipitation.
J. Immunol.
1975;114;6
Transfusion-associated hepatitis not due to viral hepatitis type A or B.
N. Engl. J. Med.
1975;292;15
Faecal shedding of hepatitis-A antigen.
Lancet
1975;1;7910
Letter: Immune electron microscopy and hepatitis A.
Lancet
1975;1;7898

Familial clustering of hepatitis B surface antigen among Panamanian Indians.
J. Infect. Dis.
1975;131;1
Immunofluorescent localization of hepatitis B antigens in chimpanzee tissues.
Intervirology
1975;6;4-5

Serologic comparison of hepatitis A antigen to echovirus 25 isolate CR69(076) recovered from a patient with viral hepatitis.
Intervirology
1975;6;4-5
Viral hepatitis.
Prev Med
1974;3;4
Viral hepatitis. Light at the end of the tunnel.
JAMA
1974;229;3
Buoyant density of the hepatitis A virus-like particle in cesium chloride.
J. Virol.
1974;13;6
Hepatitis Research.
Science
1974;184;4132
Passive hemagglutination assay for antibody to subtypes of hepatitis B antigen.
J. Immunol.
1974;112;3
Radioimmunoassay for the detection of the core of the Dane particle and antibody to it.
Intervirology
1974;2;4

The Ausria test: critical evaluation of sensitivity and specificity.
Blood
1973;42;6
DNA polymerase associated with human hepatitis B antigen.
J. Virol.
1973;12;5
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel.
N. Engl. J. Med.
1973;289;13
Differences in the prevalence of hepatitis B antigen and antibody among Panamanian Indian populations.
J. Infect. Dis.
1973;128;3
Hepatitis B antigen (HB Ag) and antibody (anti-HB Ag) in cold ethanol fractions of human plasma.
Transfusion
1972;12;6
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.
Ann. Intern. Med.
1972;77;5
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis.
J. Immunol.
1972;109;3
Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations.
Lancet
1972;2;7769
Experimental infection of chimpanzees with the virus of hepatitis B.
Nature
1972;237;5357
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation.
JAMA
1972;220;8
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen.
J. Infect. Dis.
1972;125;4
Viral hepatitis, type B (MS-2 strain). Detection of antibody after primary infection.
N. Engl. J. Med.
1971;285;6

Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation.
J. Lab. Clin. Med.
1971;77;6
Australia antigen: large-scale purification from human serum and biochemical studies of its proteins.
J. Virol.
1971;7;5
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique.
J. Immunol.
1971;106;5
Seroepidemiological studies of transfusion-associated hepatitis.
J. Infect. Dis.
1971;123;4
Mycoplasma hominis and abortion.
J. Infect. Dis.
1970;121;3
Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum.
J. Infect. Dis.
1970;121;2
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations.
JAMA
1970;211;2
Biophysical properties of Australia antigen.
J. Virol.
1969;4;5
Failure of Australia antibody to prevent post-transfusion hepatitis.
Lancet
1969;2;7620
A complement-fixation test for measuring Australia antigen and antibody.
J. Infect. Dis.
1969;120;3
Association of EB-virus infection with the post-perfusion syndrome.
Lancet
1969;1;7595
Significance of antibody to mycoplasma as measured by metabolic-inhibition techniques.
Ann. N. Y. Acad. Sci.
1967;143;1
Role of mycoplasmas in human respiratory disease.
Med. Clin. North Am.
1967;51;3
Protective effect of antibody to parainfluenza type 1 virus.
N. Engl. J. Med.
1966;275;21
Mycoplasmas of the human urogenital tract and oropharynx and their possible role in disease: a review with some recent observations.
Proc. R. Soc. Med.
1966;59;11 Part 1
Identification of acid-inducing agent and related mycoplasma as mycoplasma hyorhinis.
J. Natl. Cancer Inst.
1966;37;2

A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species.
Am. J. Epidemiol.
1966;84;1


Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.
JAMA
1966;195;6
An inactivated mycoplasma pneumoniae vaccine.
JAMA
1965;194;3
EXUDATIVE PHARYNGITIS FOLLOWING EXPERIMENTAL MYCOPLASMA HOMINIS: TYPE 1 INFECTION.
JAMA
1965;192
VIRUS OF AVIAN MYELOBLASTOSIS (BAI STRAIN A). XXIV. NUCLEOTIDE COMPOSITION OF THE PENTOSENUCLEIC ACID AND COMPARISON WITH STRAIN R (ERYTHROBLASTOSIS).
J. Natl. Cancer Inst.
1963;31
Virus of avian myeloblastosis. XX. Amino acid composition.
J. Natl. Cancer Inst.
1962;28
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.